Literature DB >> 19030865

Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis.

Gulen Hascelik1, Bengi Oz, Nese Olmez, Asuman Memis, Gazi Yoruk, Belkis Unsal, Nese Ekinci.   

Abstract

The aim of this cross-sectional study was to evaluate the frequency of intestinal inflammation and its association with disease activity, functional status and quality of life in patients with ankylosing spondylitis (AS). A total of 25 patients with AS had undergone ileocolonoscopy and concomitant histological study. Clinical and demographical parameters, BASDAI, BASFI, and SF-36 scores were compared between patients with and without macroscopic gut inflammation (MGI). Colonoscopic study revealed MGI in 9 patients and macroscopically normal gut mucosa in 16 patients. On histological examination, of 25 patients 20 had gut inflammation, mostly in ileum. BASDAI score was higher (P < 0.05), SF-36 pain and physical scores, and chest expansion measurement were lower (P = 0.00, P = 0.01, P = 0.01), duration of morning stiffness was longer (P = 0.01) in patients with MGI. Serum C-reactive protein, erytrocyte sedimentation rate levels were similar between groups (P > 0.05). There is high prevalence of histological gut inflammation in AS patients. More active disease should suggest gut inflammation in AS patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030865     DOI: 10.1007/s00296-008-0766-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

Review 1.  Bowel inflammation and the spondyloarthropathies.

Authors:  F De Keyser; D Elewaut; M De Vos; K De Vlam; C Cuvelier; H Mielants; E M Veys
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

2.  Ileocolonoscopy in patients with spondylarthritis and/or asymmetric oligoarthritis.

Authors:  L C Bedert; L S De Clerck; W J Stevens; G C Goovaerts; E K Van Marck; P P Michielson; Y M Van Maercke
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

Review 3.  Ankylosing spondylitis and bowel disease.

Authors:  Martin Rudwaleit; Dominique Baeten
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

4.  Long-term evolution of gut inflammation in patients with spondyloarthropathy.

Authors:  M De Vos; H Mielants; C Cuvelier; A Elewaut; E Veys
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 6.  Patient-assessed health in ankylosing spondylitis: a structured review.

Authors:  K L Haywood; A M Garratt; P T Dawes
Journal:  Rheumatology (Oxford)       Date:  2005-02-03       Impact factor: 7.580

Review 7.  The role of gut inflammation in the pathogenesis of spondyloarthropathies.

Authors:  H Mielants; M De Vos; C Cuvelier; E M Veys
Journal:  Acta Clin Belg       Date:  1996       Impact factor: 1.264

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.

Authors:  H Mielants; E M Veys; S Goemaere; K Goethals; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

10.  Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study.

Authors:  Albrecht Falkenbach; Annegret Franke; Sjef van der Linden
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666

View more
  6 in total

Review 1.  T helper cell subsets in arthritis and the benefits of immunomodulation by 1,25(OH)₂ vitamin D.

Authors:  Amolak S Bansal; Frances Henriquez; Nazira Sumar; Sanjeev Patel
Journal:  Rheumatol Int       Date:  2011-09-15       Impact factor: 2.631

Review 2.  Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Rheumatol Int       Date:  2014-11-11       Impact factor: 2.631

3.  Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis.

Authors:  Björn Sundström; Solveig Wållberg-Jonsson; Gunnar Johansson
Journal:  Clin Rheumatol       Date:  2010-11-27       Impact factor: 2.980

4.  Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study.

Authors:  Soo Min Ahn; Yong-Gil Kim; Seung-Hyeon Bae; Doo-Ho Lim; Seokchan Hong; Sang Hyoung Park; Chang-Keun Lee; Bin Yoo
Journal:  Korean J Intern Med       Date:  2017-08-11       Impact factor: 2.884

Review 5.  The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Clin Dev Immunol       Date:  2013-05-27

6.  Gastrointestinal Symptoms and Elevated Levels of Anti-Saccharomyces cerevisiae Antibodies Are Associated with Higher Disease Activity in Colombian Patients with Spondyloarthritis.

Authors:  C Romero-Sánchez; W Bautista-Molano; V Parra; J De Avila; J C Rueda; J M Bello-Gualtero; J Londoño; R Valle-Oñate
Journal:  Int J Rheumatol       Date:  2017-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.